Literature DB >> 21184252

Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study.

Sébastien Dilly1, Jean-François Liégeois.   

Abstract

The interaction of diazepine analogues like clozapine or olanzapine with D2 receptor was greatly affected by a mixture of HRP/H(2)O(2) known to induce the formation of nitrenium ion. Unlike diazepine derivatives, the oxidative mixture had low impact on the affinity of oxa- and thiazepine derivatives such as loxapine, clothiapine or JL13 for the D2 receptor. Molecular docking simulations revealed a huge difference between the mode of interaction of clozapine nitrenium ion and the parent drug. Electronic and geometric changes of the tricyclic ring system caused by the oxidation appeared to prevent the compound finding the correct binding mode and could therefore explain the difference observed in binding affinities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184252     DOI: 10.1007/s10822-010-9407-8

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  38 in total

1.  Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.

Authors:  S Kapur; P Seeman
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

2.  The penultimate rotamer library.

Authors:  S C Lovell; J M Word; J S Richardson; D C Richardson
Journal:  Proteins       Date:  2000-08-15

3.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  Relative contributions of desolvation, inter- and intramolecular interactions to binding affinity in protein kinase systems.

Authors:  Peter A Sims; Chung F Wong; Danka Vuga; J Andrew McCammon; Bartholomew M Sefton
Journal:  J Comput Chem       Date:  2005-05       Impact factor: 3.376

5.  Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template.

Authors:  Jana Selent; Laura López; Ferran Sanz; Manuel Pastor
Journal:  ChemMedChem       Date:  2008-08       Impact factor: 3.466

6.  Cloning and expression of a rat D2 dopamine receptor cDNA.

Authors:  J R Bunzow; H H Van Tol; D K Grandy; P Albert; J Salon; M Christie; C A Machida; K A Neve; O Civelli
Journal:  Nature       Date:  1988 Dec 22-29       Impact factor: 49.962

Review 7.  Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.

Authors:  Brian J Tabner; Stuart Turnbull; Omar M A El-Agnaf; David Allsop
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

8.  Structural features associated with reactive metabolite formation in clozapine analogues.

Authors:  J Uetrecht; N Zahid; A Tehim; J M Fu; S Rakhit
Journal:  Chem Biol Interact       Date:  1997-05-02       Impact factor: 5.192

9.  Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling.

Authors:  Li Bao; Marat V Avshalumov; Jyoti C Patel; Christian R Lee; Evan W Miller; Christopher J Chang; Margaret E Rice
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

10.  Neuroinflammation in schizophrenia-related psychosis: a PET study.

Authors:  Janine Doorduin; Erik F J de Vries; Antoon T M Willemsen; Jan Cees de Groot; Rudi A Dierckx; Hans C Klein
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

View more
  1 in total

1.  Identification and pharmacological characterization of succinate receptor agonists.

Authors:  Pierre Geubelle; Julie Gilissen; Sébastien Dilly; Laurence Poma; Nadine Dupuis; Céline Laschet; Dayana Abboud; Asuka Inoue; François Jouret; Bernard Pirotte; Julien Hanson
Journal:  Br J Pharmacol       Date:  2017-03-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.